NAGE Earning Date, Earning Analysis and Earning Prediction
Earning Analysis
Welcome to our in-depth analysis of Niagen Bioscience Inc(NAGE) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Niagen Bioscience Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
No data
Surprise Analysis
Name
EPS
Revenue
Price Reaction
Fiscal Quarter
Earning Date
Time
Estimate
Actual
Surprise%
Estimate
Actual
Surprise%
1D
5D
-
2025-11-04
After Hours
0.01
0.05
+400.00
31.10M
33.99M
+9.27
-1.01
+2.16
-
2025-08-06
After Hours
0.02
0.04
+100.00
28.31M
31.12M
+9.92
+2.23
+9.15
-
2025-05-07
After Hours
0.01
0.06
+500.00
27.08M
30.48M
+12.58
+9.35
+15.15
NAGE Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Niagen Bioscience Inc reported performance for , announced on 2025-11-04. The company achieved an EPS of 0.05, compared to analyst estimates of 0.01 by 400.00% . Revenue for the quarter reached 33.99M compared to expectations of 31.10M by 9.27% .
The stock price reacted with a -1.01% one-day change and a 2.16% five-day change following the earnings release. These movements reflect market reaction in Niagen Bioscience Inc growth trajectory and strategic initiatives.
NAGE Earnings Forecast
Looking ahead, Niagen Bioscience Inc(NAGE) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 1.03%, while EPS estimates have been Revise Upward by 26.39%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Downward by -5.9% . These revisions correlate with a -33.26% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Niagen Bioscience Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between NAGE's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
+1.03%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+26.39%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Downward
-5.9%
In Past 3 Month
Stock Price
Go Down
-33.26%
In Past 3 Month
1Y
3Y
5Y
Currency: USD
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:127.29M
--
EPS Estimate-Annual FY 2025:0.18
—
Stock Price6.46
NAGE Revenue and EPS Performance: A Historical Perspective
Niagen Bioscience Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
(2025-11-04,After Hours):
EPS: 0.05 (Actual) vs.0.01 (Estimate) (400.00%)
Revenue: 33.99M (Actual) vs. 31.10M (Estimate) (9.27%)
Price Reaction:-1.01%(1-Day), 2.16%(5-Day)
(2025-08-06,After Hours):
EPS: 0.04 (Actual) vs.0.02 (Estimate) (100.00%)
Revenue: 31.12M (Actual) vs. 28.31M (Estimate) (9.92%)
Price Reaction:2.23%(1-Day), 9.15%(5-Day)
(2025-05-07,After Hours):
EPS: 0.06 (Actual) vs.0.01 (Estimate) (500.00%)
Revenue: 30.48M (Actual) vs. 27.08M (Estimate) (12.58%)
Price Reaction:9.35%(1-Day), 15.15%(5-Day)
Earnings Reaction
The chart below shows how NAGE performed 10 days before and after its earnings report, based on data from the past quarters. Typically, NAGE sees a -0.65% change in stock price 10 days leading up to the earnings, and a +7.01% change 10 days following the report. On the earnings day itself, the stock moves by -1.49%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -1.01% on the day following the earnings release and then changed by -1.29% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
People Also Watch
Frequently Asked Questions
What were the key highlights of NAGE's latest earnings report for ?
NAGE reported its earnings on 2025-11-04, showcasing a revenue of 33.99M against an estimate of 31.10M, resulting in a 9.27% surprise. The EPS was 0.05, surpassing the expected 0.01 by 400% . The stock experienced a -1.01% price change on the earnings day and a 2.16% change over the next five days, reflecting market reactions to the results.
How did NAGE's stock price react after the earnings release?
Following NAGE's earnings announcement on 2025-11-04, the stock price moved by -1.01% on the day of the release. Over the subsequent five days, it saw a 2.16% change. Historically, NAGE's stock price tends to shift by an average of -0.65% in the 10 days leading up to earnings and +7.01% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for NAGE for undefined?
For , analysts estimate NAGE’s annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 1.03% and EPS estimates Revise Downward by -5.9% over the past three months, indicating analyst expectation in the company’s performance.
How does NAGE's stock price correlate with earnings forecast revisions?
The correlation between NAGE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 1.03%, while EPS estimates moved Revise Downward by -5.9% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from NAGE's next earnings report?
Based on historical trends, NAGE's stock price typically moves by -0.65% in the 10 days before its earnings and +7.01% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .
What is the sentiment in Niagen Bioscience Inc (NAGE) Q3 2025 Earnings Call Summary?
The earnings call shows strong financial performance, with significant revenue growth and improved net income. The strategic partnership and strong balance sheet are positive indicators. Despite some uncertainties in the Q&A, such as the new partnership's feedback and rollout timelines, the overall sentiment is positive due to the optimistic outlook on margins and potential market expansion. The absence of debt and increased cash flow bolster the positive sentiment. Without market cap data, a precise prediction is challenging, but overall indicators suggest a positive impact on the stock price.
